InvestorsHub Logo
Followers 74
Posts 15839
Boards Moderated 0
Alias Born 04/26/2010

Re: couldbebetter post# 94648

Tuesday, 10/25/2016 12:52:51 PM

Tuesday, October 25, 2016 12:52:51 PM

Post# of 423355
Interesting you should mention children - I'm sure this has already been posted, but I'll post it anyway - no way a child could safely swallow the current 1 g size cap of V, even I struggle with it at times - this opens the door for pediatric use should AMRN seek approval for that indication:

Amarin Expands Vascepa Franchise with First-and-Only 0.5-gram Prescription Omega-3 Option for Healthcare Providers Treating Patients Who Prefer a Smaller Capsule

BEDMINSTER, N.J. and DUBLIN, Ireland, Oct. 25, 2016 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) announced today the introduction of a smaller 0.5-gram capsule size for Vascepa®Â (icosapent ethyl) available now in retail pharmacies nationwide. The smaller capsule is in addition to the original and currently available 1-gram size Vascepa capsule.

"Amarin is dedicated to listening to patients and healthcare providers in an effort to deliver solutions that help make it easier for patients to take their doctor prescribed medication," said Aaron Berg, senior vice president of marketing and sales of Amarin. "We are pleased to now offer the first and only half-gram prescription omega-3 alternative for the subset of patients who prefer a smaller capsule."


The Thought Police: To censor and protect. Craig Bruce

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News